NCT01692158View on ClinicalTrials.gov

Pharmacodynamics Study of Enoxalow Compared to Clexane in Healthy Subjects After Subcutaneous Single Dose

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions
Healthy
Interventions
DRUG

Heparin, Low-Molecular-Weight

single subcutaneuous administration of 40 mg of the test drug and the comparator drug, according to randomization, in a crossover design, each administration separated by 6 days of washout.

Trial Locations (1)

13276-245

LAL Clinica, Valinhos

All Listed Sponsors
lead

Azidus Brasil

INDUSTRY

NCT01692158 - Pharmacodynamics Study of Enoxalow Compared to Clexane in Healthy Subjects After Subcutaneous Single Dose | Biotech Hunter | Biotech Hunter